Navigation Links
Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
Date:11/12/2009

PRINCETON, N.J. and SAN DIEGO, Nov. 12 /PRNewswire/ -- Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers. The two studies, a single-ascending dose (SAD) study and the multiple-ascending dose (MAD) study, were undertaken to assess the pharmacokinetics, safety and tolerability of TBR-652 in two tablet formulations under fasted and fed conditions, respectively. In the SAD study 2 cohorts of 12 subjects were randomized per dose level; each subject received up to 3 single escalating doses of study drug. Dosing followed an overnight fast of at least 8 hours. In the MAD study, 5 dose groups of 12 subjects each were randomized to receive drug daily for 10 days. Doses were either in the same formulation as the SAD study (F1) or a newer formulation (F2). Doses were taken within 10 minutes after completion of a standard high-fat breakfast. Subjects in both studies were followed for 10 days after the last dose of TBR-652.

TBR-652 was readily absorbed in both tablet formulations achieving mean peak plasma concentrations in 4-6 hours. A 25 mg/day F1 or F2 tablet achieved plasma exposures greater than the target therapeutic level of 2ng/mL projected from in vitro studies of TBR-652. TBR-652 was eliminated from plasma with linear kinetics and similar half-lives (mean approximately 35-40 hours) across dose levels. This elimination half-life is sufficiently long to support once-daily dosing.

TBR-652 was well-tolerated at single daily doses up to 800 mg and once-daily doses of up to 200 mg for 10 days. Headache, diarrhea, abdominal pain and nausea were the most commonly encountered treatment-emergent events; all AEs resolved by the end of both studies. "The results fro
'/>"/>

SOURCE Tobira Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
2. Tobira Therapeutics Inc. Receives US Patent for TBR-652
3. Reportlinker Adds Pain Therapeutics 2005: Market Dynamics and Outlook
4. Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009
5. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
6. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
7. Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
8. Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor
9. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
10. Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
11. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... WOODCLIFF LAKE, N.J. and SAN ... announced today that its parent company Eisai Co., Ltd. ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. ... and CEO: Dr. Helen Torley , "NASDAQ: HALO") ... eribulin mesylate (brand name: Halaven ® , "eribulin") in ...
(Date:7/30/2015)... Calif. , July 30, 2015 Edwards Lifesciences ... science of heart valves and hemodynamic monitoring, today announced that ... Board of Directors. "Bob is an ardent champion ... a true privilege to have him on Edwards, board as ... Mussallem , Edwards, chairman and CEO.  "Bob has provided a ...
(Date:7/30/2015)... Inc. (NYSE: RMD ) today announced results for ... quarter was $453.1 million, a 9 percent increase compared ... percent increase on a constant currency basis).  Net income ... 30, 2014.  Diluted earnings per share for the quarter ... 2014.  The results for the quarter ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... Oct. 14 The U.S. ... Planning and Evaluation (ASPE) has selected Thomson Reuters ... enable researchers to perform comparative effectiveness studies without ... (Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO ) (Logo: ...
... highlights the need for Anesthesia Information Management Systems (AIMS) ... access to day-of-surgery data is Extremely Important ... department.  More than half of the survey respondents are ... OR.  The independent survey of 277 anesthesiologists was sponsored ...
Cached Medicine Technology:Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research 2New Survey Highlights Immediate Need for Anesthesia Information Management Systems 2New Survey Highlights Immediate Need for Anesthesia Information Management Systems 3
(Date:8/1/2015)... ... August 01, 2015 , ... Western University of ... profession” that comprises a growing percentage of U.S. physicians, and reflects the diversity ... one part of the message delivered by John W. Becher, DO, president of ...
(Date:8/1/2015)... ... , ... Tina Wilcoxson, owner of Freeport Maine’s Royal River Natural Foods, was ... National Retail Federation, the largest retail trade association in the world, for her “advocacy ... to be named as such. According to the NRF’s website, Retail Champions are “Main ...
(Date:8/1/2015)... , ... August 01, 2015 , ... Lume Wellness creators ... is free to download on the Apple AppStore. , The app is designed ... mood, thus acting as a tool to view personal health and use this information ...
(Date:7/31/2015)... Rosa, CA (PRWEB) , ... July 31, 2015 ... ... posted by High Times magazine. What are the STASH awards? The Significant ... advances made by the cannabis-cultivation community as well as tried-and-true products that have ...
(Date:7/31/2015)... ... , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA ... the Super Bowl. In the two weeks that separate the conference championships and the Super ... Super Bowl game will mark the 50th time it has been held and the festivities ...
Breaking Medicine News(10 mins):Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Local Retail Advocate Wins National Recognition 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... ATLANTA, Oct. 30 Even though many hospitals ... automate their surgery,processes, those that do see significant ... care. A case study recently,published by Kermit Randa ... The Work Group, Inc., outlines the benefits realized ...
... (NYSE:,HRC) today announced a new agreement with Encompass ... Quantum(TM) VPC Support,Systems for use with Hill-Rom(R) bed ... in our relationship with Encompass,",said Mary Butler, executive ... Hill-Rom. "This agreement is part of our focus ...
... in Emerging Food Processing Market for SDC, ... today announced that the United States Patent and ... process for treating,consumable food products with silver dihydrogen ... new patent expands the scope of,protection of PURE,s ...
... adds Women,s Hospital to Growing List of New Breast ... Inc. (Pink,Sheets: SNDY) is pleased to announce that the ... purchased and are now in use,at the Women,s Hospital ... employs advanced micro endoscopes and optical technology to,give physicians ...
... to acid in the mouth is the culprit, pediatric dentist ... its avalanche of candy is coming, making it the worst ... says a dentist who contends that parents can make a ... , "Parents need to know that frequency is far ...
... Cancidas and Astellas,s Mycamine Cut Prices, According To New Data ... from Arlington Medical Resources, ... of premier market intelligence for the pharmaceutical and,diagnostic imaging industries, finds ... classes: 10.7 percent of all courses,in the January - June 2008 ...
Cached Medicine News:Health News:Healthcare Providers Improve Financial, Clinical and Operational Efficiencies Through IT 2Health News:Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames 2Health News:Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames 3Health News:PURE Bioscience Granted US Patent on SDC for Food Treatment 2Health News:PURE Bioscience Granted US Patent on SDC for Food Treatment 3Health News:Solos Endoscopy, Inc.'s Mammo View(TM) System Now Used in Women's Hospital of Baton Rouge, LA 2Health News:Halloween Candy: It's Not How Much Kids Eat, It's When 2Health News:Halloween Candy: It's Not How Much Kids Eat, It's When 3Health News:Echinocandins Show Growth Among All Antifungal Classes 2Health News:Echinocandins Show Growth Among All Antifungal Classes 3
MAGNETOM Symphony, an imaging system that offers 1.5T performance and top image quality in a short bore design....
... MAGNETOM Trio with Tim™ (Total ... workflow, highest speed, and highest resolution ... up to 16, advanced applications can ... routine. MAGNETOM Trio with Tim is ...
... It enables you to scan every beating heart ... radiation dose possible. A scanner using two ... time. It provides one-stop diagnosis in acute care; ... heart rate. Combined with the Cardiac Engine, a ...
... Assistant (MBA) is a Microsoft ... practice management software package. MBA ... Server technology and is HIPAA ... account receivable management, MBA allows ...
Medicine Products: